Advertisement
Research Article Free access | 10.1172/JCI111789
Find articles by Thiagarajan, P. in: JCI | PubMed | Google Scholar
Find articles by Shapiro, S. in: JCI | PubMed | Google Scholar
Find articles by Levine, E. in: JCI | PubMed | Google Scholar
Find articles by DeMarco, L. in: JCI | PubMed | Google Scholar
Find articles by Yalcin, A. in: JCI | PubMed | Google Scholar
Published March 1, 1985 - More info
We have previously described a series of monoclonal antibodies against platelet membrane glycoproteins. Two of the antibodies, B59.2 and B2.12, recognize the glycoprotein IIb-IIIa complex. These two antibodies react specifically with glycoprotein (GP) IIIa, as shown by immunoblotting of sodium dodecyl sulfate-polyacrylamide gels of solubilized platelet membranes. Monoclonal B2.12, but not B59.2, binds to cultured human endothelial cells obtained from umbilical vein, internal iliac artery, and inferior vena cava. At saturation approximately 100,000 binding sites were detected per human umbilical vein endothelial cell. When solubilized radioiodinated cells were chromatographed on a column of agarose-bound B2.12, a single radiolabeled protein was obtained whose apparent molecular weight is slightly larger than that of platelet GP IIIa. This protein incorporated [35S]methionine when endothelial cells were labeled metabolically. These results demonstrate that human endothelial cell membranes synthesize a protein immunologically related to platelet GP IIIa.
Images.